Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients

Lupus

Volumn 14, Issue 12, 2005, Pages 938-946

  Garcia, Mercedes A ^a   Marcos, J C ^a   Marcos, A I ^a   Pons Estel, B A ^b   Wojdyla, D ^c   Arturi, A ^a   Babini, J C ^a   Catoggio, L J ^d   Alarcon Segovia, Donato ^e  

^a Hospital Interzonal General de Agudos de La Plata   (Argentina)

^b Hospital Eva Peron   (Argentina)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Gender; Latin American; Male SLE; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CENTRAL AMERICA; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; DISEASE COURSE; FEMALE; FEVER; GENDER; HEMOLYTIC ANEMIA; HUMAN; HYPERTENSION; KIDNEY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SOUTH AMERICA; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LATIN AMERICA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 30644472966     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2245oa     Document Type: Article

References (37)

1. Campos LM, Kiss MH, D'Amico EA, Silva CA. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 2003; 12: 820-26.
2. Wang LC, Yang YH, Lu MY, Chiang BL. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect 2003; 36: 203-208.
3. D-M Chang, C-C Chang, S-Y Kuo, S-J Chu, M-L Chang. The clinical features and prognosis of male lupus in Taiwan. Lupus 1998; 7: 462-68.
4. Petri M. Male lupus differs from female lupus in presentation and outcome. Lupus 1998; 7(Suppl 1): 84 (abstract).
5. Wallace DJ. A reason for the rarity of male lupus. Lupus 1998; 7: 60.
6. Pons-Estel BA, Catoggio LJ, Cardiel MH et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus. Ethnic and disease heterogeneity among 'Hispanics'. Medicine 2004; 83: 1-17.
7. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-77.
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
9. Gladman DD, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-69.
10. Gladman DD, Urowitz MB, Goldsmith CH et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-813.
11. Collett, D. Modelling survival data in medical research. Chapman and Hall, 1994: p 347.
12. Manger K, Manger B, Repp R et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 2002; 61: 1065-70.
13. López, P, Mozo L, Gutierrez C, Suárez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003; 12: 860-65.
14. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Ethnicy and gender differences. Arthritis Rheum 1995; 38: 1260-70.
15. Vilar MJ, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus 2002; 11:528-32.
16. Othmani S, Louzir B. Systemic lupus erythematosus in 24 Tunisian males: clinical, laboratory and evolution analysis. Rev Med Interne 2002; 23: 983-90.
17. Arbuckle MR, James JA, Dennis GJ et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 2003; 12: 99-106.
18. Li H, Li X, Chu G, Liu J, Bi Z. A clinic analysis of 62 male patients with lupus nephritis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2000; 22: 395-7.
19. Tabechian D, Pattanaik D, Suresh U, Cohn SE, Nadasdy T. Lupus-like nephritis in an HIV-positive patient: report of a case and review of the literature. Clin Nephrol 2003; 60: 187-94.
20. Saltoglu N, Tasova Y, Midikli D, Aksu HS, Sanli A, Dundar IH. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect 2004; 48: 81-85.
21. Williams W, Bhagwanddass A, Sargeant LA, Shah D. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse cyclophosphamide therapy in Jamaican patients. Lupus 2000; 12: 640-45.
22. Appenzeller S, Marini R, Costallat LT. Damage did not independently influence mortality in childhood systemic lupus erythematosus. Rheumatol Int 2005; 25: 619-24.
23. Massardo L, Jacohelli S. Occassional Series: Lupus Around the World. The Chilean experience of systemic lupus erythematosus. Lupus 1996; 5: 175-77.
24. Molina JF, Drenkard C, Molina J et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Bait.) 1996; 75: 124-30.
25. Alarcon G, Friedman AW, Straaton KV et al. Systemic lupus erythematous in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 1999; 8: 197-209.
26. Arbuckle MR, James JA, Dennis GJ et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 2003; 12: 99-106.
27. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Bait.) 2003; 82: 299-308.
28. Marchini M, Antonioli R, Lleo A et al HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol 2003; 64: 462-8.
29. Tucci M, Barnes EV, Sobel ES et al. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 2004; 50: 1842-49.
30. Liang MH, Mandl LA, Costenbader K, Fox E, Karlson E. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc 2002; 94: 813-19.
31. Asanuma Y, Oeser A, Shintani AK et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. New Engl J Med 2003; 349: 2407-15.
32. Barile LA, Jara LJ, Medina-Rodriguez F, Garcia-Figuero JL, Miranda-Limon JM. Pulmonary hemorrhage in systemic lupus erythematosus. Lupus 1997; 6: 445-48.
33. Spitzer JA. Gender differences in some host defense mechanisms. Lupus 1999; 8: 380-83.
34. Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 2000; 9: 252-57.
35. James WH. Is hypoandrogenism a cause or a consequence of systemic lupus erythematosus in male patients? Lupus 2000; 9: 646.
36. Chang DM, Chang CC, Kuo SY, Chu SJ, Chang ML. Hormonal profiles and immunological studies of male lupus in Taiwan. Clin Rheumatol 1999; 18: 158-62.
37. Gabriel SE. The epidemiology of gender-discrepant illness. Lupus 1999; 8: 339-45.